Nucletron has announced that the first Esteya electronic brachytherapy system in the US has been installed at New York's Memorial Sloan-Kettering Cancer Center. Esteya by Nucletron, an Elekta company, is a new approach for skin cancer ...
Tags: Nucletron, Skin Cancer
Nucletron, an Elekta Company, has obtained 510(k) approval from the US Food and Drug Administration (FDA) for Esteya electronic brachytherapy system, a new approach for high precision skin cancer treatment. Depending on a small, high dose ...